Aerovate Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Aerovate Therapeutics's balance sheet done over the years? Its assets were worth $127,418,000 last year, which is less than in the previous period. 14% of Aerovate Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $17,962,000, which means an increase by 110% compared compared to last year.

Debt to Assets

Aerovate Therapeutics, Inc. (NASDAQ:AVTE): Debt to assets
2019 3514000 7.15M 203.67%
2020 4715000 18.05M 383.01%
2021 175363000 2.94M 1.68%
2022 135301000 8.55M 6.33%
2023 127418000 17.96M 14.1%

AVTE Balance Sheet (2019 – 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
23.49M22.39M54.19M4.57M3.51M
Short term investments
98.94M106.82M113.17M00
Net receivables
00000
Inventory
00000
Other current assets
1.79M295K240K103K0
Total current assets
124.23M131.49M174.33M4.67M3.51M
Non-current assets:
Property, Plant and Equipment
902K1.24M728K39K0
Goodwill
00000
Intangible assets
00000
Long term investments
00000
Other non-current assets
2.28M2.56M302K00
Total non-current assets
3.18M3.80M1.03M39K0
Total assets
127.41M135.30M175.36M4.71M3.51M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
001.00M00
Short term debt
840K385K192K00
Total current liabilities
17.63M7.78M2.55M1.77M657K
Non-current liabilities:
Long term debt
255K705K382K02.5M
Deferred tax
00000
Other non-current liabilities
70K71K13K04M
Total non-current liabilities
325K776K395K16.28M6.5M
Total liabilities
17.96M8.55M2.94M18.05M7.15M
Data sourceData sourceData source